Concomitant in Medical News

FDA Approves SAMSCA(TM) (tolvaptan), the First and Only Oral Vasopressin Antagonist to Treat Patients With Clinically Significant Hypervolemic and Euvolemic Hyponatremia

... respond to thirst, hypovolemic hyponatremia, concomitant use of strong CYP 3A inhibitors, anuric patients ... not use with strong inhibitors of CYP 3A; avoid concomitant use with moderate CYP 3A inhibitors CYP 3A Inducers - Avoid concomitant use with CYP 3A inducers. If co-administered, the ...

Cimzia(R) (certolizumab pegol) Now Available for Self-Administration in Adult Patients With Moderate to Severe Crohn's Disease

... who developed these infections were taking concomitant immunosuppressants such as methotrexate ... taking CIMZIA 200 mg every other week with concomitant methotrexate (n=640) and more frequently than with placebo with concomitant methotrexate (n=324) were upper respiratory tract ...

UCB's CIMZIA(R) (certolizumab pegol) Approved by the U.S. FDA for Adult Patients Suffering From Moderate to Severe Rheumatoid Arthritis

... who developed these infections were taking concomitant immunosuppressants such as methotrexate or ... taking CIMZIA 200 mg every other week with concomitant methotrexate (n=640) and more frequently than with placebo with concomitant methotrexate (n=324) were upper respiratory tract ...

Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Commercial Availability of Savella(TM)

... reuptake, including Savella, particularly with concomitant use of serotonergic drugs (including triptans and ... metabolism of serotonin (including MAOIs). The concomitant use of Savella with serotonin precursors is not ... regarding the risk of bleeding associated with concomitant use of Savella and NSAIDs, aspirin, warfarin or ...

FDA Approves Symbyax(R) as First Medication for Treatment-Resistant Depression

... Safety Information for Symbyax and concomitant Use of Zyprexa and Fluoxetine Symbyax is ... at least five weeks after stopping Symbyax. concomitant use of Symbyax in patients taking pimozide is ... Symbyax treatment, but particularly with concomitant use of serotonergic drugs, including triptans, ...

Forest Laboratories, Inc. Announces FDA Approval of Lexapro(R) for the Treatment of Major Depressive Disorder in Adolescents

... events. Patients should be cautioned that concomitant use of aspirin, NSAIDs, warfarin and other ... intervention should be instituted. The concomitant use of Lexapro with other SSRIs, SNRIs, triptans, ... immediate discontinuation of Lexapro and the concomitant agent and continued monitoring. Patients ...

Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Revised Timing for Commercial Availability of Savella(TM)

... reuptake, including Savella, particularly with concomitant use of serotonergic drugs (including triptans and ... metabolism of serotonin (including MAOIs). The concomitant use of Savella with serotonin precursors is not ... regarding the risk of bleeding associated with concomitant use of Savella and NSAIDs, aspirin, warfarin or ...

European Commission and United States Food and Drug Administration (FDA) Both Approve New Options for Patients With Certain Primary Brain Tumors

... in a fatal outcome. In some cases, exposure to concomitant medications associated with aplastic anemia ... pneumonia is required for all patients receiving concomitant TEMODAR(R) and radiotherapy for the 42-day ... adverse reactions in clinical studies in the concomitant Phase (Radiotherapy + TEMODAR(R)) and the ...

Prescription Copay Assistance for Patients taking Gleevec or Tasigna for Philadelphia chromosome-positive Chronic Myelogenous Leukemia (Ph+ CML)

... monitored closely. Drug interactions The concomitant use of QT prolonging drugs and strong inhibitors ... Concomitant strong CYP3A4 inhibitors The concomitant use of strong CYP3A4 inhibitors should be avoided ... Concomitant strong CYP3A4 inducers The concomitant use of strong CYP3A4 inducers should be avoided ...

Forest and Cypress Announce FDA Approval of Savella(TM) for the Management of Fibromyalgia

... reuptake, including Savella, particularly with concomitant use of serotonergic drugs (including triptans and ... metabolism of serotonin (including MAOIs). The concomitant use of Savella with serotonin precursors is not ... regarding the risk of bleeding associated with concomitant use of Savella and NSAIDs, aspirin, warfarin or ...

Concomitant treatment with nebulized formoterol fumarate & tio-significant improvements -- COPD

... over the course of the 6-week study. concomitant Treatment with Nebulized Formoterol and ... Medicine, assesses the efficacy and safety of the concomitant treatment of Perforomist nebulized formoterol ... additional insight into the additive benefit of concomitant therapy with a LABA and a long-acting ...

Wyeth's Pristiq, a New Treatment for Major Depressive Disorder in Adults, Now Available in U.S. Pharmacies

... SSRIs, including PRISTIQ, particularly with concomitant use of serotonergic drugs, including triptans, ... metabolism of serotonin (including MAOIs). If concomitant use is clinically warranted, careful observation ... treatment initiation and dose increases. concomitant use of PRISTIQ with serotonin precursors is not ...

CryoCor Reports Publication in Circulation for Treatment of Atrial Fibrillation

... paroxysmal atrial fibrillation with and without concomitant right atrial flutter. During follow-up averaging ... ablation was successful in patients without concomitant atrial flutter at an 82% success rate. In patients with concomitant atrial flutter, the combination of ablation ...

GlaxoSmithKline Obtains Exclusive U.S. OTC Marketing Rights to MEVACOR(R) (lovastatin) from Merck & Co., Inc.

... risk of myopathy/rhabdomyolysis is increased by concomitant use of lovastatin with the following: Potent ... (>1 quart daily) should be avoided. concomitant use of other medicines labeled as having a potent ... not exceed 20 mg daily in patients receiving concomitant medication with other fibrates or Greater Than or ...

Clinical trial data: Safety/efficacy of concomitant formoterol fumarate/tiotropium treating COPD

... College of Chest Physicians (ACCP), demonstrate concomitant use of nebulized formoterol fumarate and ... presented were from Safety and Efficacy of concomitant Treatment with Nebulized Formoterol and ... Phase IIIb trial. The trial demonstrated that concomitant therapy with twice-daily nebulized formoterol ...

NYU Langone Medical Center's tip sheet to the 45th Annual Meeting of ASCO

... of a key protein that normally promotes melanoma survival and a concomitant 81 percent increase in cancer cells that were programmed to die. The ... was given to 24 glioblastoma patients who also received radiation and concomitant chemotherapy; another 31 patients received similar treatments but without ...

Retrospective Analysis Finds Treatment of Cancer Chemotherapy Patients With Epoetin Alfa Associated With Lower Drug Cost Than Darbepoetin Alfa

... EPO or DARB, received two or more EPO or DARB doses and were treated with concomitant chemotherapy during the treatment episode. The average treatment ... cell transfusion. Use ESAs only for treatment of anemia due to concomitant myelosuppressive chemotherapy. ESAs are not indicated for ...

New Once-Daily RYZOLT(TM) (tramadol HCl extended-release tablets) Now Available in the U.S.

... range. Seizure risk is increased with doses above the recommended range. concomitant use of tramadol hydrochloride increases the seizure risk in patients ... with the use of tramadol products, including RYZOLT, particularly with concomitant use of serotonergic drugs such as SSRIs, SNRIs, TCAs, MAOIs, and triptans, ...

Brain tumors: New therapy surprisingly successful

... Up to now, doctors have treated glioblastomas using radiotherapy with concomitant chemotherapy. The "gold standard" for this for the last few years has been ... we tested. It is possible that a simple gene test could decide for whom a concomitant chemotherapy might be of benefit". One disadvantage of the new method are ...

New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes

... Recommended Dosing Patients with Renal Insufficiency concomitant Use with a Sulfonylurea DOSAGE FORMS AND STRENGTHS ... the Cockcroft-Gault formula. [See Clinical Pharmacology (12.3). concomitant Use with a Sulfonylurea When JANUVIA is used in combination with a ...

Concomitant use of Perforomist & tiotropium -- significant improvements -- COPD

... Conference of the American Thoracic Society (ATS) demonstrate that concomitant therapy with Perforomist Inhalation Solution (formoterol fumarate ... team for their careful investigation into the clinical benefits of concomitant therapy of Perforomist and tiotropium. At DEY, we are committed to ...

AtriCure Reports Fourth Quarter and Full Year 2007 Record Financial Results

... rhythm in patients with permanent atrial fibrillation, or AF, requiring concomitant open-heart surgery utilizing the Cox Maze IV procedure. ABLATE is expected ... Synergy(TM) bipolar ablation system when used to treat patients undergoing concomitant open-heart surgery. The principal investigator of the ABLATE trial is Dr. ...

TAXUS(R) Liberte(TM) Drug-eluting Coronary Stent System Receives CE Mark for Use in Diabetic Patients

... The TAXUS Liberte stent system is also indicated for patients with concomitant diabetes mellitus as well as treatment of abrupt or threatened closure in ... Boston Scientific Corporation References (1) For patients with concomitant diabetes mellitus. (2) Ormiston J, Mahmud E, Mandinov L, et al. TAXUS ...

Cystic Fibrosis foundation lays out new treatment guidelines

... with Pseudomonas (this recommendation excludes patients who have concomitant asthma); Inhaled corticosteroids, because there was no clinical benefit (this recommendation excludes patients who have concomitant asthma); and Prophylactic anti-Staphylococcal antibiotics because of ...

Akela Pharma announces final positive results from its growth hormone releasing hormone (GHRH) Phase II trial

... were associated with a significant increase in Fat Free Mass (FFM), and concomitant reduction in Fat Mass (FM) when measured by DEXA scan and bioelectrical ... from baseline in FFM (median 3.3 kg by BIA and 1.6 kg by DEXA) and a concomitant decrease in FM (median 1.8 kg by BIA and 0.4 kg by DEXA). These changes ...

Video and Photo: Tasigna(R) Receives US Approval Providing New Hope to Chronic Myeloid Leukemia Patients With Resistance or Intolerance to Existing Therapies

... and QT interval should be monitored closely. Drug interactions: Avoid concomitant use of strong inhibitors or inducers of CYP3A4. If patients must be ... to tolerate the reintroduction of Gleevec at a lower dose with or without concomitant corticosteroids or antihistamines following resolution or improvement of ...

FDA Approves LIVALO(R) for Primary Hypercholesterolemia and Combined Dyslipidemia

... for a broad range of patients including the elderly, patients with diabetes and those whose treatment is complicated by concurrent disease and concomitant medications. About Dyslipidemia and Hypercholesterolemia Dyslipidemia refers to abnormal levels of fatty substances in the blood, ...

INVEGA(R) Approved as the First and Only Treatment for Schizoaffective Disorder

... mg with the option to reduce to 3 mg, or 12 mg with the option to reduce to 9 mg. In addition to study medication, subjects were permitted to receive concomitant treatment with a mood stabilizer and/or antidepressant, provided these medications had been given at a stable dose within 30 days of screening. ...

FDA Approves TYVASO (Treprostinil) Inhalation Solution for the Treatment of Pulmonary Arterial Hypertension

... TYVASO may cause symptomatic hypotension. TYVASO may also increase the risk of bleeding, particularly in patients receiving anticoagulants. The concomitant use of TYVASO with diuretics, antihypertensives or other vasodilators may increase the risk of systemic hypotension. Hepatic or renal insufficiency ...

MULTAQ(R) (dronedarone) for Atrial Fibrillation or Atrial Flutter Now Available in the United States

... has a rapid onset, reaches a plateau after 7 days and is reversible after discontinuation. Hypokalemia and hypomagnesemia may occur with concomitant administration of potassium-depleting diuretics. Potassium levels should be maintained in the normal range pre and during administration. ...

Radiology Informatics: Frost & Sullivan Examines the Next Big Wave in Medicine

... Its aim is to assist radiologists in arriving at a quicker interpretation and also contribute towards recommending other necessary actions for concomitant requirements. Reporting errors, wrong interpretations, and patient report delays due to an unavailability of radiologists will eventually be ...

FDA Approves Multaq(R) for Patients with Atrial Fibrillation or Atrial Flutter

... has a rapid onset, reaches a plateau after 7 days and is reversible after discontinuation. Hypokalemia and hypomagnesemia may occur with concomitant administration of potassium-depleting diuretics. Potassium levels should be maintained in the normal range pre and during administration. For ...

Novo Nordisk Insulin Analogs Have Proven Safety Profiles

... to be adjusted in patients with renal or hepatic impairment. Levemir(R) should not be diluted or mixed with any other insulin preparations. concomitant oral antidiabetes treatment may require adjustment. Levemir(R) is not to be used in insulin infusion pumps. Inadequate dosing or discontinuation ...

NUCYNTA(TM) (tapentadol) CII Immediate Release Tablets Now Available for Relief of Moderate to Severe Acute Pain

... The development of a potentially life-threatening serotonin syndrome may occur with use of SNRI products, including NUCYNTA,(TM) particularly with concomitant use of serotonergic drugs such as SSRIs, SNRIs, TCAs, MAOIs and triptans, and with drugs which impair metabolism of serotonin (including MAOIs). ...

Health Care Reform May Force U.S. Pharmaceutical Companies to Overhaul Sales Strategies, Says New Report From ZS Associates and eyeforpharma

... influence over physician prescription decisions in the United States. So even if a pharmaceutical company fails to obtain a favored spot -- and the concomitant smaller co-pay -- for its drug on a payer's formulary in the United States, physicians and patients still can opt for the drug. This contrasts ...

Novo Nordisk Warns Customers About Stolen Insulin

... Levemir (R) is not to be used in insulin infusion pumps. Any change of insulin dose should be made cautiously and only under medical supervision. concomitant oral antidiabetes treatment may require adjustment. Inadequate dosing or discontinuation of treatment may lead to hyperglycemia and, in ...

Wistar Institute team finds key target of aging regulator

... telomeresis important for yeast cells to maintain the ability to replicate. Researchers found that Sir2 levels decline as cells age, and there is a concomitant accumulation of the acetylation mark along with disrupted histone organization at telomeres. Deacetylation of H4K16 by Sir2 and consequent ...

White Paper Explains Package Validation Requirements For Medical Devices & Combinatory Products

... develop a robust packaging validation regimen That a packaging validation program should include transportation simulation testing with concomitant sterility testing. A comprehensive regulatory approach to validation during early product development can save many weeks of redevelopment ...

AstraZeneca Studies Show Relief of Nighttime Heartburn and Reduction in GERD-Related Sleep Disturbances

... with the absorption of drugs where gastric pH is an important determinant of bioavailability (e.g., ketoconazole, iron salts, and digoxin). concomitant use of NEXIUM and atazanavir or nelfinavir is not recommended because the plasma concentrations and therapeutic effects of those antiretroviral drugs ...

New Data Demonstrate RISPERDAL(R) CONSTA(R) (Risperidone) Long-Acting Treatment May Improve Health Outcomes and Reduce Hospitalizations in Patients with Schizophrenia

... antipsychotic drugs and other drugs not essential to concurrent therapy, intensive symptomatic treatment and medical monitoring, and treatment of any concomitant serious medical problems. Tardive Dyskinesia (TD): TD is a syndrome of potentially irreversible, involuntary, dyskinetic movements that may ...